Verition Fund Management’s Usana Health Sciences USNA Stock Holding History

Verition Fund Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,400	Closed	-$231K	–	3971
2025 Q3	$231K	Sell	8,400 -22,708	-73%	-$699K	﹤0.01%	3416
2025 Q2	$950K	Buy	+31,108	New	+$883K	﹤0.01%	2509
2025 Q1	–	Sell	-9,002	Closed	-$323K	–	3739
2024 Q4	$323K	Buy	+9,002	New	+$337K	﹤0.01%	2742
2024 Q1	–	Sell	-4,291	Closed	-$230K	–	2990
2023 Q4	$230K	Buy	+4,291	New	+$217K	﹤0.01%	1945
2020 Q3	–	Sell	-2,915	Closed	-$214K	–	1382
2020 Q2	$214K	Buy	+2,915	New	+$229K	0.01%	934
2019 Q3	–	Sell	-2,767	Closed	-$220K	–	1350
2019 Q2	$220K	Buy	+2,767	New	+$219K	0.01%	951
2018 Q4	–	Sell	-5,574	Closed	-$672K	–	1287
2018 Q3	$672K	Buy	+5,574	New	+$692K	0.02%	723

Other funds holding USNA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's USNA Position: Q4 2025 in Review

Verition Fund Management sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 8,400 shares — an estimated $231K sold.

Verition Fund Management first reported a position in USNA in Q3 2018 and held it in 7 quarters. The position peaked at $950K in Q2 2025. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

Verition Fund Management reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
Verition Fund Management sold 8,400 Usana Health Sciences shares in Q4 2025, an estimated $231K.
Verition Fund Management first reported a position in Usana Health Sciences in Q3 2018 and held it in 7 quarters.
Verition Fund Management's Usana Health Sciences position peaked at $950K in Q2 2025.
121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.